Translational potential of targeting Anoctamin-1-Encoded Calcium-Activated chloride channels in hypertension

Area of Science:

• Physiology
• Pharmacology
• Cardiovascular Research

Background:

• Calcium-activated chloride channels (CaCC), including Anoctamin-1 (ANO1/TMEM16A), regulate cellular depolarization via chloride efflux.
• ANO1 is implicated in smooth muscle tone in diverse blood vessels, suggesting potential roles in cardiovascular conditions.
• The precise involvement of ANO1 in systemic and portal hypertension remains less defined compared to pulmonary hypertension.

Purpose of the Study:

• To review the current understanding of ANO1's role in hypertension across systemic, portal, and pulmonary vascular systems.
• To evaluate the therapeutic potential and challenges of targeting ANO1 for hypertension treatment.

Main Methods:

• Literature review of studies investigating ANO1 function in vascular smooth muscle.
• Analysis of research on ANO1's contribution to vascular tone and its association with hypertension.
• Synthesis of findings across different vascular beds (systemic, portal, pulmonary).

Main Results:

• ANO1's role in pulmonary hypertension is established, but its contribution to systemic and portal hypertension is less clear.
• ANO1 significantly influences vascular tone, but its specific role in hypertension pathogenesis varies by vascular system.
• ANO1's diverse physiological functions across multiple tissues complicate targeted therapeutic strategies.

Conclusions:

• ANO1's complex and varied roles in vascular systems necessitate a cautious approach to its therapeutic targeting for hypertension.
• Tissue-selective strategies may be required to effectively target ANO1 for hypertension treatment while minimizing off-target effects.
• Further research is needed to elucidate ANO1's precise mechanisms in systemic and portal hypertension.